Literature DB >> 10768985

Humanized in vivo model for streptococcal impetigo.

D A Scaramuzzino1, J M McNiff, D E Bessen.   

Abstract

An in vivo model for group A streptococcal (GAS) impetigo was developed, whereby human neonatal foreskin engrafted onto SCID mice was superficially damaged and bacteria were topically applied. Severe infection, indicated by a purulent exudate, could be induced with as few as 1,000 CFU of a virulent strain. Early findings (48 h) showed a loss of stratum corneum and adherence of short chains of gram-positive cocci to the external surface of granular keratinocytes. This was followed by an increasing infiltration of polymorphonuclear leukocytes (neutrophils) of mouse origin, until a thick layer of pus covered an intact epidermis, with massive clumps of cocci accumulated at the outer rim of the pus layer. By 7 days postinoculation, the epidermis was heavily eroded; in some instances, the dermis contained pockets (ulcers) filled with cocci, similar to that observed for ecthyma. Importantly, virulent GAS underwent reproduction, resulting in a net increase in CFU of 20- to 14,000-fold. The majority of emm pattern D strains had a higher gross pathology score than emm pattern A, B, or C (A-C) strains, consistent with epidemiological findings that pattern D strains have a strong tendency to cause impetigo, whereas pattern A-C strains are more likely to cause pharyngitis.

Entities:  

Mesh:

Year:  2000        PMID: 10768985      PMCID: PMC97500          DOI: 10.1128/IAI.68.5.2880-2887.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

Review 2.  Differences between streptococcal infections of the throat and of the skin. I.

Authors:  L W Wannamaker
Journal:  N Engl J Med       Date:  1970-01-01       Impact factor: 91.245

3.  Localization of immunoglobulin A-binding sites within M or M-like proteins of group A streptococci.

Authors:  D E Bessen
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.

Authors:  D Bessen; V A Fischetti
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

5.  A human IgG receptor of group A streptococci is associated with tissue site of infection and streptococcal class.

Authors:  D Bessen; V A Fischetti
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

6.  Selective distribution of a high-affinity plasminogen-binding site among group A streptococci associated with impetigo.

Authors:  M D Svensson; U Sjöbring; D E Bessen
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Molecular evolution of a multigene family in group A streptococci.

Authors:  S K Hollingshead; J Arnold; T L Readdy; D E Bessen
Journal:  Mol Biol Evol       Date:  1994-03       Impact factor: 16.240

8.  Bactericidal effect of oleic acid on group A streptococci: mechanism of action.

Authors:  D P Speert; L W Wannamaker; E D Gray; C C Clawson
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

9.  Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin.

Authors:  H S Courtney; W A Simpson; E H Beachey
Journal:  J Bacteriol       Date:  1983-02       Impact factor: 3.490

10.  Experimental infections with group A streptococci in humans.

Authors:  J J Leyden; R Stewart; A M Kligman
Journal:  J Invest Dermatol       Date:  1980-08       Impact factor: 8.551

View more
  26 in total

1.  Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes.

Authors:  Awdhesh Kalia; Brian G Spratt; Mark C Enright; Debra E Bessen
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 3.  Tissue tropisms in group A streptococcal infections.

Authors:  Debra E Bessen; Sergio Lizano
Journal:  Future Microbiol       Date:  2010-04       Impact factor: 3.165

4.  Whole-genome association study on tissue tropism phenotypes in group A Streptococcus.

Authors:  Debra E Bessen; Nikhil Kumar; Gerod S Hall; David R Riley; Feng Luo; Sergio Lizano; Candace N Ford; W Michael McShan; Scott V Nguyen; Julie C Dunning Hotopp; Hervé Tettelin
Journal:  J Bacteriol       Date:  2011-09-23       Impact factor: 3.490

5.  Incremental Contributions of FbaA and Other Impetigo-Associated Surface Proteins to Fitness and Virulence of a Classical Group A Streptococcal Skin Strain.

Authors:  Candace N Rouchon; Anhphan T Ly; John P Noto; Feng Luo; Sergio Lizano; Debra E Bessen
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

6.  Role of streptococcal T antigens in superficial skin infection.

Authors:  Sergio Lizano; Feng Luo; Debra E Bessen
Journal:  J Bacteriol       Date:  2006-09-29       Impact factor: 3.490

7.  Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing.

Authors:  Zhihong Xie; Angela Thompson; Takanori Sobue; Helena Kashleva; Hongbin Xu; John Vasilakos; Anna Dongari-Bagtzoglou
Journal:  J Infect Dis       Date:  2012-10-02       Impact factor: 5.226

Review 8.  Pathogenesis of mucosal biofilm infections: challenges and progress.

Authors:  Anna Dongari-Bagtzoglou
Journal:  Expert Rev Anti Infect Ther       Date:  2008-04       Impact factor: 5.091

9.  Heterogeneity in the polarity of Nra regulatory effects on streptococcal pilus gene transcription and virulence.

Authors:  Feng Luo; Sergio Lizano; Debra E Bessen
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

10.  Characterization of mucosal Candida albicans biofilms.

Authors:  Anna Dongari-Bagtzoglou; Helena Kashleva; Prabhat Dwivedi; Patricia Diaz; John Vasilakos
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.